Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China flag China · Delayed Price · Currency is CNY
11.29
+0.16 (1.44%)
Feb 4, 2026, 3:04 PM CST

SHE:000590 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
155.73177.29189.77235.42250.68342.95
Trading Asset Securities
33--25.1175.15-
Cash & Short-Term Investments
188.73177.29189.77260.53325.83342.95
Cash Growth
-0.85%-6.58%-27.16%-20.04%-4.99%9.10%
Accounts Receivable
73.6103.15154.4117.16124.81111.22
Other Receivables
33.7590.2860.5130.1161.82
Receivables
107.35193.43214.91147.27130.82113.04
Inventory
114.91124.78130.09118.2286.5950.82
Prepaid Expenses
-2.32-0.0300.57
Other Current Assets
20.242.174.793.0610.651.23
Total Current Assets
431.23499.99539.55529.11553.88508.62
Property, Plant & Equipment
312.97312.66293.81289.75240.89224.73
Long-Term Investments
23.6220.0320.91919-
Goodwill
13.213.2131.64137.14--
Other Intangible Assets
126.13131.06132.33157.44133.69138.16
Long-Term Accounts Receivable
2.093.095.057.42--
Long-Term Deferred Tax Assets
11.568.184.095.234.974.56
Long-Term Deferred Charges
6.586.293.322.931.821.84
Other Long-Term Assets
18.218.9220.421913.5714.25
Total Assets
945.591,0131,1511,167967.83892.16
Accounts Payable
62.0573.2483.5564.0141.6738.62
Accrued Expenses
19.3243.8846.6250.840.3733.29
Short-Term Debt
-0.75-25.82-5
Current Portion of Long-Term Debt
7.2311.011010.1--
Current Portion of Leases
-2.942.362.693-
Current Income Taxes Payable
6.026.82.33.43.853.99
Current Unearned Revenue
24.3545.3350.1256.1353.4226.35
Other Current Liabilities
43.4952.3153.8258.4544.6853.76
Total Current Liabilities
162.46236.26248.77271.42186.98161.02
Long-Term Debt
99.1282.228090--
Long-Term Leases
1.881.493.075.185.59-
Long-Term Unearned Revenue
45.7343.9942.4444.3746.2941.57
Long-Term Deferred Tax Liabilities
4.755.155.917.470.02-
Other Long-Term Liabilities
45.843.0742.7246.0946.6244.69
Total Liabilities
359.74412.18422.92464.53285.5247.27
Common Stock
239.47239.47239.47239.47239.47239.47
Additional Paid-In Capital
474.06474.06474.06474.06474.06474.06
Retained Earnings
-130.11-115.2910.18-15.06-33.21-68.65
Total Common Equity
583.43598.25723.72698.47680.32644.88
Minority Interest
2.432.994.494.032-
Shareholders' Equity
585.85601.23728.2702.5682.32644.88
Total Liabilities & Equity
945.591,0131,1511,167967.83892.16
Total Debt
108.2398.4295.43133.798.585
Net Cash (Debt)
80.578.8794.34126.74317.24337.95
Net Cash Growth
-2.23%-16.40%-25.56%-60.05%-6.13%7.51%
Net Cash Per Share
0.340.330.390.531.321.41
Filing Date Shares Outstanding
239.47239.47239.47239.47239.47239.47
Total Common Shares Outstanding
239.47239.47239.47239.47239.47239.47
Working Capital
268.77263.73290.78257.69366.9347.6
Book Value Per Share
2.442.503.022.922.842.69
Tangible Book Value
444.1453.98459.75403.89546.63506.72
Tangible Book Value Per Share
1.851.901.921.692.282.12
Buildings
-267.95247.28243.93198.81145.94
Machinery
-220.21197.31189.09174.95137.89
Construction In Progress
-8.8123.8315.214.1879.44
Source: S&P Global Market Intelligence. Standard template. Financial Sources.